| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 5,190,837 | 161,746,000 | 49.08% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 2,664,970 | 65,318,000 | 19.82% | ||
| 3 | BIO-REFERENCE LABS INC | 900,000 | 37,125,000 | 11.26% | ||
| 4 | Opko Health, Inc. | 14,000,000 | 33,131,000 | 10.05% | PRN | |
| 5 | BIOMARIN | 182,300 | 24,935,000 | 7.57% | ||
| 6 | MERRIMACK PHARMACEUTI | 3,500,000 | 7,328,000 | 2.22% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-15-006097, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
